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In Brief
The alternative lengthening of telomeres
pathway accounts for cellular immortality
in 10% of all cancers; however, the
mechanisms regulating ALT activity have
not been fully elucidated. Cox et al.
demonstrate that the replication stress
response protein SMARCAL1 is
significantly enriched at ALT telomeres to
resolve replication stress and promote
ALT activity.
Cell Reports
ReportSMARCAL1 Resolves Replication Stress
at ALT Telomeres
Kelli E. Cox,1,2 Alexandre Mare´chal,3 and Rachel Litman Flynn1,2,*
1Department of Pharmacology and Experimental Therapeutics
2Department of Medicine, Cancer Center
Boston University School of Medicine, Boston, MA 02118, USA
3Department of Biology, Universite´ de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada
*Correspondence: rlflynn@bu.edu
http://dx.doi.org/10.1016/j.celrep.2016.01.011
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
Cancer cells overcome replicative senescence by
exploiting mechanisms of telomere elongation, a
process often accomplished by reactivation of the
enzyme telomerase. However, a subset of cancer
cells lack telomerase activity and rely on the alterna-
tive lengthening of telomeres (ALT) pathway, a
recombination-based mechanism of telomere elon-
gation. Although the mechanisms regulating ALT
are not fully defined, chronic replication stress at
telomeres might prime these fragile regions for
recombination. Here, we demonstrate that the repli-
cation stress response protein SMARCAL1 is a crit-
ical regulator of ALT activity. SMARCAL1 associates
with ALT telomeres to resolve replication stress
and ensure telomere stability. In the absence of
SMARCAL1, persistently stalled replication forks at
ALT telomeres deteriorate into DNA double-strand
breaks promoting the formation of chromosome
fusions. Our studies not only define a role for
SMARCAL1 in ALT telomere maintenance, but also
demonstrate that resolution of replication stress is
a crucial step in the ALT mechanism.
INTRODUCTION
Telomeres cap the ends of chromosomes and function as a bar-
rier shielding the human genome from nucleolytic degradation
and illegitimate recombination. Telomeres are composed of
double-stranded TTAGGG hexameric repeats that are organized
into a lariat, or T-loop, at the end of each chromosome (Palm and
de Lange, 2008). While this structure is essential to prevent chro-
mosome ends from being recognized as DNA double strand
breaks (DSBs), T-loops pose a natural impediment to DNA repli-
cation (Fouche´ et al., 2006; Poulet et al., 2009; Uringa et al.,
2012; Vannier et al., 2013; Sarek et al., 2015). In addition, the
G-rich sequence drives Hoogsteen base-pairing between gua-
nosine nucleotides generating G-quadruplex structures that
pose a threat to the processivity of the replication machinery
(Sen and Gilbert, 1988; Sundquist and Klug, 1989). The repetitive1032 Cell Reports 14, 1032–1040, February 9, 2016 ª2016 The Authonature and structural complexities of the telomeric DNA induce
frequent replication fork stalling and chromosome breakage
demonstrating that telomeres are common fragile sites within
the genome (Verdun and Karlseder, 2006; Sfeir et al., 2009; Mar-
tı´nez et al., 2009). Therefore, understanding how cells have
evolved to navigate the replication stress associated with telo-
meric DNA is essential to our understanding of genome stability.
Common fragile sites are associated with an increased rate
of recombination suggesting that telomere fragility promotes
recombination at telomere ends (Glover and Stein, 1987;
Schwartz et al., 2005). The link between telomere fragility and
recombination is most evident in cancer cells that rely on the
alternative lengthening of telomeres (ALT) pathway. The ALT
pathway promotes telomere elongation using homology-
directed recombination between telomeric DNA sequences
(Bryan et al., 1995; Dunham et al., 2000; London˜o-Vallejo et al.,
2004). Although in cancer cells telomere elongation is often
achieved by reactivation of the enzyme telomerase, subsets of
cancer cells activate the ALT pathway for telomere maintenance
(Henson and Reddel, 2010). The exact mechanisms driving acti-
vation andmaintenance of the ALT pathway are not fully defined,
however, telomere deprotection and changes in chromatin dy-
namics may represent early events in the ALT process. In ALT
cells, the telomere sequence has evolved such that in addition
to the canonical TTAGGG sequence these telomeres have
an increase in variant hexameric repeats including TCAGGG,
TTCGGG, and GTAGGG (Conomos et al., 2012; Varley et al.,
2002). Variant repeats drive telomere deprotection by disrupting
binding of the telomere repeat factors TRF1 and TRF2; com-
ponents of the telomere capping complex, Shelterin. Loss of
TRF1 increases replication fork stalling and enhances telomere
fragility (Sfeir et al., 2009; Martı´nez et al., 2009). This fragility is
exacerbated by defects in nucleosome assembly at telomeres
as genetic mutations in the chromatin remodeling complex
a-thalassemia/mental retardation syndrome X-linked/death-
domain-associated protein (ATRX/DAXX) and histone variant
H3.3 are highly correlated with ALT positive cancers (Heaphy
et al., 2011; Schwartzentruber et al., 2012). In addition, loss of
the histone chaperone ASF1 (anti-silencing factor 1) in mamma-
lian cells, which promotes histone transfer during replication,
leads to the induction of ALT-like phenotypes (O’Sullivan et al.,
2014). Therefore, limited telomere end protection and altered
chromatin dynamics stress an already fragile repetitive regionrs
during replication, enhancing replication stress and conse-
quently promoting telomere instability. Together, these events
may prime telomeres for recombination and as a result promote
ALT activity.
The telomeric DNA in ALT cells is incredibly dynamic
constantly undergoing rapid attrition and elongation providing
one of the first indications that telomeres in ALT cells rely on
recombination to promote telomere elongation (Bryan et al.,
1995). This was later supported by studies demonstrating that
the telomeres in ALT cells are recruited into nuclear foci that, in
addition to the promyelocytic leukemia (PML) protein, contain
a number of recombination and repair factors including RPA,
RAD51, RAD52, BRCA1, MRE11, RAD50, and NBS1 (Yeager
et al., 1999; Wu et al., 2000, 2003; Grudic et al., 2007). The for-
mation of the ALT-associated PML bodies (or APB) led to early
speculations that APB functioned as platforms for recombina-
tion. More recently, it was demonstrated that inhibition of repli-
cation, or the sensing of replication stress, could disrupt APB for-
mation (O’Sullivan et al., 2014; Flynn et al., 2015). These findings
raise the possibility that as common fragile sites, replication fork
stalling at the telomere drives APB formation to either promote
fork restart or salvage collapsed forks through recombination.
Given the repetitive nature of telomeres, recombination can
occur between nonhomologous chromosomes, sister chroma-
tids, or extrachromosomal telomeric repeat (ECTR) DNA. ECTR
DNA can exist in both linear and circular forms composed of
double stranded or partially single-stranded, C-rich or G-rich te-
lomeric sequences (Tokutake et al., 1998; Nabetani and Ishi-
kawa, 2009). Partially single-stranded C-rich circular ECTR, or
C-circles are unique to ALT cells and have been demonstrated
to directly correlate with ALT activity (Lau et al., 2013; Henson
et al., 2009). ECTR are likely generated as a byproduct of recom-
bination, however, they may also perpetuate the ALT phenotype
by functioning as a template for recombination (Henson and
Reddel, 2010). Similar to the formation of APB, C-circle forma-
tion is significantly reduced following inhibition of replication,
or the sensing of replication stress (O’Sullivan et al., 2014; Flynn
et al., 2015). Taken together, these cellular phenotypes highlight
the contribution of replication stress to telomere recombination,
and ultimately, provocation of the ALT pathway.
Given the fragility of telomeric DNA, understanding how the
telomere responds to replication stress will undoubtedly further
our understanding of both telomere maintenance and the
progression toward cancer. Recently, the annealing helicase
SMARCAL1 was identified as one of the most abundant proteins
bound to persistently stalled, or collapsed, replication forks
(Sirbu et al., 2013; Dungrawala et al., 2015). SMARCAL1 (SWI/
SNF-related, matrix-associated, actin-dependent regulator of
chromatin, subfamily A-like 1), also known as the HepA-related
protein (HARP), is an ATP-dependent DNA annealing helicase
that remodels chromatin surrounding stalled replication forks
to promote replication restart (Yusufzai and Kadonaga, 2008;
Bansbach et al., 2009; Be´tous et al., 2012; Yuan et al., 2009).
Therefore, we speculated that SMARCAL1 might function to
remodel stalled replication forks at telomeric DNA and bolster
replication through a particularly fragile region. Here, we demon-
strate that SMARCAL1 is enriched at telomeric DNA in cells that
rely on the ALT pathway for telomeremaintenance indicating thatCell RALT telomeres are prone to chronic replication stress. In the
absence of SMARCAL1, persistently stalled replication forks
at ALT telomeres form DNA double-strand breaks, induce
RAD51-dependent telomere clustering, promote chromosomal
fusions, and drive genome instability. Our studies demonstrate
a function for SMARCAL1 in the resolution of replication stress
at telomeric DNA and also define SMARCAL1 as a critical regu-
lator of the ALT pathway. Defining the molecular mechanisms
regulating maintenance of the ALT pathway is critical to both
our understanding of telomere biology and also the progression
toward cancer.
RESULTS AND DISCUSSION
SMARCAL1 Is Significantly Enriched at ALT Telomeres
SMARCAL1 was identified as a chromatin remodeling enzyme
that functions to restart stalled replication forks by catalyzing
branch migration and fork regression (Be´tous et al., 2012; Bans-
bach et al., 2009; Yuan et al., 2009). Given the prevalence of
replication stress at telomeres, we asked whether SMARCAL1
functioned to alleviate replication stress and promote telomere
maintenance. To do this, we initially asked whether SMARCAL1
associated with telomeric DNA in unperturbed mammalian cells.
Using a combined immunofluorescence and in situ hybridization
(IF-FISH) approach, we detected SMARCAL1 protein at telo-
meres in ALT positive SaOS2ALT and HuO9ALT cells (Figures 1A
and 1B), however, we did not detect SMARCAL1 at telomeres
in telomerase-positive HeLaTEL or untransformed RPEUNT cells
(Figures 1A, 1B, and S1A). The association of SMARCAL1 with
telomeres in ALT positive cells was robust with 60% of cells
demonstrating at least one SMARCAL1-telomere colocalization
event (Figure 1B). Remarkably, this association of SMARCAL1
with telomeres was restricted exclusively to APB as we were
unable to detect SMARCAL1 at telomeres that had not been
recruited to PML bodies (Figures 1C and 1D). The association
of SMARCAL1 with ALT telomeres was not simply attributed to
highly repetitive regions as we could not detect SMARCAL1 at
centromeric DNA by IF-FISH (Figure S1B). To further validate
the specificity of SMARCAL1 binding at telomeric DNA, we per-
formed chromatin immunoprecipitation assays. Similar to the
results from our IF-FISH experiments, SMARCAL1 was signifi-
cantly enriched at the telomeric DNA in SaOS2ALT cells but not
in HeLaTEL cells (Figures 1E and 1F). Moreover, the binding of
SMARCAL1 at ALT telomeres was significantly enriched over
SMARCAL1 binding to the Alu repeats further highlighting the
specificity of SMARCAL1 binding at ALT telomeres (Figures
S1C and S1D).
To further understand the association of SMARCAL1 with ALT
telomeres, we asked whether we could promote SMARCAL1 re-
localization to non-ALT telomeres by inducing replication stress.
To do this, we took advantage of a HeLaTEL cell line derivative
that maintains long telomeres, HeLaTEL1.2.11 and consequently,
is vulnerable to replication stress. In fact, even in undamaged
HeLaTEL1.2.11 cells, we could detect rare instances of colocaliza-
tion between SMARCAL1 and telomeric DNA by IF-FISH. To
determinewhether these infrequent colocalizationeventsare truly
representative of sites of replication stress, we asked whether
we could increase the frequency of these events by inducingeports 14, 1032–1040, February 9, 2016 ª2016 The Authors 1033
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Figure 1. SMARCAL1 Accumulates at ALT
Telomeres
(A) Combined immunofluorescence and DNA
fluorescence in situ hybridization (IF-FISH) ana-
lyses of SMARCAL1 and telomeres in SaOS2,
HuO9, and HeLa cells. Representative images are
shown. Scale bar, 10 mm.
(B) The percentage of cells positive for 0, 1–2, 3–4,
5–6, and 7 or greater incidences of SMARCAL1
colocalizing with telomeres in SaOS2, HuO9, and
HeLa cells are graphed as the mean of three in-
dependent experiments (n = 3). Scale bar, 10 mm.
(C) IF-FISH analyses of SMARCAL1, PML, and
telomeres in SaOS2 and HuO9 cells. Scale bar,
10 mm.
(D) Quantification of experiments performed in
(C). Percentage of cells positive for APB and
SMARCAL1 colocalizing with APB are graphed as
the mean ± SD (n = 2).
(E) ChIP for telomeric DNA associated with
SMARCAL1 and TRF2 in SaOS2 and HeLa
cells co-expressing FLAG-SMARCAL1 and MYC-
TRF2.
(F) Quantification of dot blots performed in (E).
Graph represents average percent of telomeric
DNA recovered in two independent experi-
ments ± SD.
See also Figure S1.replication stress specifically at telomere ends. Considering
the role of TRF1 in telomere replication, we asked whether loss
of TRF1 would induce frequent fork stalling at telomeres
and promote the accumulation of SMARCAL1 at telomeric
DNA in HeLaTEL1.2.11 cells. Therefore, we depleted TRF1 from
HeLaTEL1.2.11 cells and either left themuntreated or exacerbated
replication stresswith aphidicolin and analyzed the association of
SMARCAL1 with telomeric DNA by IF-FISH. In the absence of
TRF1, cells treated with aphidicolin demonstrated an increase in
the phosphorylated form of RPA pS4/S8 at telomere ends, and
these foci colocalized with SMARCAL1 suggesting the formation
of irreversibly stalled replication forks (Figures S1E–S1G) (Niu
et al., 1997; Vassin et al., 2004; Mare´chal and Zou, 2015). These
results demonstrate that SMARCAL1 does in fact associate with
non-ALT telomeres, but this association is highly dependent on
replication stress (Poole et al., 2015). Moreover, the abundance
of SMARCAL1 at telomeres in ALT cells in the absence of exoge-1034 Cell Reports 14, 1032–1040, February 9, 2016 ª2016 The Authorsnous replication stress suggests that ALT
telomeres undergo chronic replication
stress highlighting an unexplored function
for SMARCAL1 in maintenance of the ALT
pathway.
Loss of SMARCAL1 Promotes
Telomere Clustering in ALT
The association of SMARCAL1 with ALT
telomeres led us to hypothesize that
SMARCAL1 localizes to telomeres in
ALT to resolve persistently stalled replica-
tion forks and promote telomere stability.Thus, we predicted that loss of SMARCAL1 in ALT would lead to
defects in replication fork restart, promote the accumulation of
collapsed replication forks, and consequently increase APB for-
mation. Consistent with this reasoning, loss of SMARCAL1 led to
a significant increase in the percentage of cells positive for APB
(Figures 2A–2C) highlighting the contribution of replication stress
to APB formation. SMARCAL1 loss did not lead to changes in the
distribution of cells throughout the cell cycle, ruling out the pos-
sibility that the accumulation of APB was a result of cell-cycle ar-
rest (Figure S2A). In addition to the increase in APB, we observed
a17-fold increase inmean telomere foci size in a subset of cells
depleted for SMARCAL1, as compared to the mean telomere
foci size in control cells (Figure S2B). The percentage of cells
with large telomere foci increased by 4-fold following SMAR-
CAL1 depletion in the ALT positive cells SaOS2ALT, CAL72ALT,
and HuO9ALT (Figures 2D and S2C). In contrast, these large
telomeric foci were entirely absent in HeLaTEL cells further
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Figure 2. SMARCAL1 Inhibits the Forma-
tion of Double-Stranded DNA Breaks at
Telomeres
(A) SaOS2 cells were mock-treated or treated with
SMARCAL1 siRNA for 72 hr, and PML and telo-
mere foci were analyzed by IF-FISH. Scale bar,
10 mm.
(B) The percentage of cells positive for APB
(colocalization of PML and telomere) was graphed
as the mean ± SD (n = 3). *p < 0.005.
(C) Western blot of SMARCAL1 in SaOS2 cells
either mock-treated or treated with SMARCAL1
siRNA for 72 hr. Tubulin is used as a loading
control.
(D) Representative images of DNA FISH analyses
of telomere foci in HeLa, CAL72, HuO9, and
SaOS2 cells either mock-treated or treated with
SMARCAL1 siRNA for 72 hr. Scale bar, 10 mm.
(E) Quantification of experiments performed in (D).
Graph represents percentage of cells positive for
telomere R2 mm was graphed as the mean ± SD
(n = 3 SaOS2, n = 2 HuO9, and CAL72). *p < 0.0001
(SaOs2), *p < 0.05 (HuO9), *p < 0.001 (CAL72).
(F) SaOS2 cells were mock-treated or treated with
SMARCAL1 siRNA for 72 hr, and gH2AX and
telomere foci were analyzed by IF-FISH. Scale bar,
10 mm.
(G) Quantification of experiments performed in (F).
Graph represents percentage of cells positive for
colocalization of gH2AX and telomere foci was
graphed as the mean ± SD (n = 3). *p < 0.005.
(H) SaOS2 cells were either mock-treated, co-
treated with Mus81 siRNA and SLX4 siRNA,
treated with SMARCAL1 siRNA alone, or treated
with SMARCAL1 siRNA, Mus81 siRNA, and SLX4
siRNA for 72 hr. Telomere foci were analyzed by
DNA FISH. Scale bar, 10 mm.
(I) Quantification of experiments performed in (H).
Graph represents average percentage of cells
positive for telomere fociR2 mm ± SD (n = 5Mock,
n = 2 siSLX4/siMus81, n = 5 siSM1, n = 5 siSM1/
siSLX4/siMus81). *p < 0.05.
See also Figure S2.supporting a unique role for SMARCAL1 at ALT telomeres (Fig-
ure 2D). Furthermore, we also observed an increase in the large
telomere foci size using an alternative small interfering RNA
(siRNA) targeting the 30 UTR of SMARCAL1. Importantly, we
could rescue the large telomere phenotype in these cells
with exogenously expressed Flag-SMARCAL1 (Figures S2D
and S2E).
Large telomere foci size has been linked to the aggregation
of telomeric DNA following the formation of DNA DSBs (Cho
et al., 2014). Therefore, we considered the possibility that the
larger telomeric foci following SMARCAL1 knockdown may
reflect sites of persistent stalled replication forks that break-
down into DNA DSBs. The percentage of cells demonstrating
the large telomere phenotype steadily accumulated over time,
reaching a maximum of 60% cells containing larger telomeric
foci after 5 days (Figures S2F and S2G). These large foci wereCell Rspecific to telomeric DNA as we did not observe an increase in
centromeric DNA foci size in the absence of SMARCAL1 (Fig-
ure S2H). Finally, the large telomeric foci demonstrated a signif-
icant increase in colocalization with gH2AX reinforcing the
speculation that these telomeres represent sites of DSBs (Fig-
ures 2F and 2G).
Stalled replication forks represent a roadblock to cellular pro-
liferation. Therefore, persistently stalled forks are subject to
cleavage by the SLX-MUS endonuclease complex (Fekairi
et al., 2009; Hanada et al., 2007; Wyatt et al., 2013). Once
cleaved, these replication forks are repaired through homolo-
gous recombination (Mun˜oz et al., 2009; Petermann et al.,
2010). The SLX4 and MUS81 nuclease have been shown to
localize to APB in ALT cells and regulate ALT activity (Zeng
et al., 2009; Sarkar et al., 2015). Therefore, we asked whether
the SLX-MUS endonuclease complex was responsible for theeports 14, 1032–1040, February 9, 2016 ª2016 The Authors 1035
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Figure 3. Loss of SMARCAL1 Promotes
RAD51-Dependent Telomere Clustering
(A) SaOS2 cells were either mock-treated or
treated with SMARCAL1 siRNA for 72 hr, pRPA
S4/S8 and telomere foci were analyzed by
IF-FISH. Scale bar, 10 mm.
(B) SaOS2 cells were either mock-treated or
treated with SMARCAL1 siRNA for 72 hr, and
RAD51 foci were analyzed by IF-FISH. Scale bar,
10 mm.
(C) Quantification of experiments performed in
(A) and (B). Graph represents the average per-
centage of cells positive for colocalization of
RAD51 (left bar) and pRPA S4/S8 (right bar) with
telomere fociR2 mm.
(D) SaOS2 cells were either mock-treated, treated
with SMARCAL1 siRNA alone, RAD51 siRNA
alone, or co-treated with SMARCAL1 siRNA and
RAD51 siRNA for 72 hr. Telomere foci were
analyzed by DNA FISH. Scale bar, 10 mm.
(E) Western blot of SMARCAL1 and RAD51 in
SaOS2 cells either mock-treated, treated with
SMARCAL1 siRNA alone, RAD51 siRNA alone, or
co-treated with SMARCAL1 siRNA and RAD51
siRNA after 72 hr. Tubulin was used as a loading
control.
(F) Quantification of experiments performed in (D).
Graph represents average percentage of cells with
telomere fociR2 mm ± SD (n = 3). *p < 0.05.
(G) SaOS2 cells were either mock-treated or
treated with SMARCAL1 siRNA for 72 hr, and PML
and telomere foci were analyzed by IF-FISH.
Graph represents telomere foci R 2 mm colo-
calized with zero, one, or two or greater PML foci.
See also Figure S3.generation of the large telomere foci formed in ALT cells
following SMARCAL1 knockdown. In fact, in SMARCAL1-defi-
cient ALT cells also containing siRNA for MUS81 and SLX4, we
observed a significant decrease in the percentage of cells con-
taining the large telomeric foci (Figures 2H, 2I, S2I, and S2J). Pre-
vious studies have demonstrated that SMARCAL1 prevents the
formation of MUS81-dependent DNA DSBs (Be´tous et al., 2012).
Therefore, our data suggest that loss of SMARCAL1 in ALT cells
leads to irreversibly stalled replication forks at telomeric DNA
that are recognized and cleaved by the SLX-MUS endonuclease
complex driving DSB formation.
The generation of DSBs at ALT telomeres promotes RAD51-
dependent telomeric clustering and consequently, primes telo-
meres for homology-directed repair (Cho et al., 2014). Thus,1036 Cell Reports 14, 1032–1040, February 9, 2016 ª2016 The Authorswe asked whether the DSBs at telomeric
DNA in ALT cells following loss of
SMARCAL1 also promote telomere clus-
tering. In fact, following SMARCAL1
knockdown, we observed a significant
increase in the association of pRPA S4/
S8 with large telomere foci suggesting
that these telomere ends contain irrevers-
ibly stalled replication forks that have
collapsed into DSBs (Figures 3A and 3C)(Niu et al., 1997; Vassin et al., 2004; Mare´chal and Zou, 2015).
Concomitant with RPA-coated telomeric DNA was the accumu-
lation of the recombination protein RAD51 (Figures 3B and 3C).
Notably, formation of the large telomere foci was dependent
on RAD51 as SMARCAL1-deficient cells treated with RAD51
siRNA showed a significant reduction in large telomere foci (Fig-
ures 3D–3F). These foci were largely devoid of 53BP1 although in
some instances we could detect 53BP1 on the periphery of the
foci highlighting the increase in DNADSBs and damage signaling
at these telomere ends (Figure S3A). Similar to previous reports,
these telomere clusters colocalized with PML, and a single large
telomere often containedmore than a single PML foci reinforcing
the model that PML functions to promote telomere-telomere in-
teractions (Figures 3G and S3B) (Cho et al., 2014; Draskovic
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Figure 4. Loss of SMARCAL1 Increases ALT
Activity and Induces Structural Chromo-
some Abnormalities
(A) SaOS2 cells were either mock-treated or
treated with SMARCAL1 siRNA for 12 days before
isolation of genomic DNA. The isolated DNA was
then digested and telomere restriction fragments
were analyzed by Southern blot using telomere-
specific probes.
(B) SaOS2 cells were either mock-treated or
treated with SMARCAL1 siRNA for 72 hr. C-circle
amplification products were loaded onto mem-
branes by dot blot and analyzed by Southern blot
using a telomere-specific probe.
(C) The levels of C-circles were graphed as the
mean ± SD (n = 3). *p < 0.05.
(D) Representative metaphase spread of mock-
treated (top) or SMARCAL1 siRNA-treated (bottom)
RPE (left) and SaOS2 (right) cells after 72 hr.
Enlarged images represent incidence of chro-
matid-type fusions. Scale bar, 10 mm.
(E) Quantification of experiments performed in (D).
Graph represents percentage of metaphase
spreads positive for fusion events containing R 3
chromosomes and was graphed as mean ± SD
(n = 2,R16 spreads per experiment).
See also Figure S4.et al., 2009). Taken together, our data suggest that loss of
SMARCAL1 induces DSBs at ALT telomeres and triggers
RAD51-dependent telomere clustering.
SMARCAL1 Regulates ALT Activity
To further define the role of SMARCAL1 in ALT telomere mainte-
nance, we asked whether DSBs and subsequent telomere clus-
tering induced by SMARCAL1 loss would lead to significant
changes in overall telomere heterogeneity. Therefore, we per-
formed telomere restriction fragment (TRF) analysis on genomic
DNA isolated from SMARCAL1-deficient cells. Loss of SMAR-
CAL1 led to an increase in smaller telomeric DNA fragments
that migrate below the bulk telomere signal as well as an in-
crease in larger telomeric DNA fragments migrating above the
bulk telomere signal (Figure 4A). These findings suggest that
loss of SMARCAL1 leads to gross changes in telomere he-
terogeneity and supports a role for SMARCAL1 in maintaining
ALT telomere stability. While the increase in smaller telomericCell Reports 14, 1032–1040,DNA fragments could be explained by
the increase in DNA DSBs following
SMARCAL1 knockdown, we speculated
that the larger telomeric DNA fragments
could represent unresolved recombina-
tion intermediates.
The sheer abundance of telomeric DNA
throughout the genome allows re-
combination during ALT to occur between
homologous and/or nonhomologous
chromosomes, chromosome fragments,
and/or ECTR DNA. The C-rich circular
ECTR DNA species, or C-circles, areunique to ALT-positive cells and have been shown to directly
correlate with ALT activity. C-circles are thought to arise as by-
products of telomeric recombination and can be readily de-
tected by Southern blot following rolling-circle amplification. If
the DSBs formed after loss of SMARCAL1 promote recombina-
tion, we predicted that SMARCAL1 knockdown in ALT cells
would lead to an increase in C-circle formation. As predicted,
following SMARCAL1 knockdown, we demonstrate a 3-fold in-
crease in C-circle abundance in ALT cells (Figures 4B and 4C).
However, in stark contrast, SMARCAL1 knockdown did not
induce C-circle formation in HeLaTEL cells demonstrating that
loss of SMARCAL1 can increase, but cannot induce, ALT activity
(Figures S4A–S4C). To determine whether the increase in ALT
activity and large telomere DNA fragments are indicative of unre-
solved recombination intermediates, we analyzed metaphase
chromosome spreads from SMARCAL1-deficient SaOS2ALT
and RPEUNT cells. Remarkably, in the absence of SMARCAL1
in SaOS2ALT cells we observed metaphase spreads containingFebruary 9, 2016 ª2016 The Authors 1037
chromatid-type fusions (Figures 4D and 4E). However, these
structural chromosome abnormalities were absent in RPEUNT
cells following SMARCAL1 knockdown (Figures 4D and 4E).
Conceivably, in the absence of SMARCAL1, DNA DSBs formed
by persistently stalled replication forks at ALT telomeres are
forced to undergo recombination leading to an increase in ALT
phenotypes. The increase in ALT telomeres primed for recombi-
nation overwhelms the repair machinery leading to defects in the
resolution of recombination intermediates and emergence of
structural chromosome abnormalities.
In conclusion, we have demonstrated that the annealing heli-
case SMARCAL1 is a critical regulator of replication stress at te-
lomeric DNA. The enrichment of SMARCAL1 at telomeres in ALT
cells demonstrates that ALT telomeres experience chronic repli-
cation stress and highlight SMARCAL1 as a critical regulator of
the ALT pathway. SMARCAL1 associates with telomeric DNA
in ALT cells and functions tomitigate replication stress and regu-
late ALT activity. Together, our data support a model in which
SMARCAL1 binds ALT telomeres to resolve replication stress
and facilitate telomere elongation. However, in the absence of
SMARCAL1 stalled replication forks fail to restart and conse-
quently, become substrates for cleavage by the SLX-MUS endo-
nuclease complex. The formation of telomeric DNA DSBs drives
telomere clustering and facilitates recombination to salvage
collapsed replication forks and maintain telomere stability.
Nevertheless, the accumulation of telomeric DNA DSBs
following SMARCAL1 depletion saturates the capabilities of
the repair machinery leading to the formation of unresolved
recombination intermediates and genome instability. The enrich-
ment of SMARCAL1 at ALT telomeres highlights both the preva-
lence of replication stress at ALT telomeres and also how reso-
lution of this replication stress is critical for the maintenance of
ALT activity. The ALT pathway is active in 10% of all cancers;
thus, further defining the mechanisms regulating ALT activity
could provide an opportunity for targeted therapeutic
development.
EXPERIMENTAL PROCEDURES
Cell Culture
SaOS2 cells were grown in McCoy’s 5A, 15% FBS, and 1% penicillin/strepto-
mycin. HeLa and HeLa 1.2.11 cells were cultured in DMEM, 10% FBS, 1%
L-glutamine, and 1% penicillin/streptomycin. RPE and Cal72 cells were grown
in DMEM F12, 10% FBS, 1% and penicillin/streptomycin. SJSA1 and HuO9
cells were grown in RPMI 1640, 5% FBS, 1% sodium pyruvate, and 1% peni-
cillin/streptomycin.
siRNAs, Probes, Antibodies, and Plasmids
All siRNA transfections were performed using Invitrogen RNAi MAX according
tomanufacturer’s instructions. Plasmids were transfected using Fugene trans-
fection reagent. Additional information described in the Supplemental Exper-
imental Procedures.
Combined Immunofluorescence FISH
Cells were rinsed with PBS, treated with cytobuffer (100mMNaCl, 300mM su-
crose, 3 mMMgCl2, 10 mM PIPES [pH 7], 0.1% Triton X-100), and fixed in 4%
paraformaldehyde. Cells were then permeabilized in 0.5% NP40/PBS and
blocked in PBG (0.5%BSA, 0.2% fish gelatin, PBS). Cells were then incubated
with indicated antibodies diluted in PBG. Cells were washed with PBS and
incubated with secondary antibody diluted in PBG. The cells were washed
with PBS and fixed in 4% paraformaldehyde. This was followed by digestion1038 Cell Reports 14, 1032–1040, February 9, 2016 ª2016 The Authowith RNaseA 200 mg/ml. Cells were then dehydrated in a series of ethanol
washes 70%, 85%, 100%, and the coverslips were dried. Ten nanomolar
PNA-TAMRA-(CCCTAA) probe in hybridization buffer (50% formamide, 23
SSC, 2 mg/ml BSA, 10% dextran sulfate) was added to coverslips and DNA
was and then placed in a humidified chamber overnight. The coverslips
were washed in 23 SSC +50% formamide, 23 SSC alone, and finally in 23
SSC containing DAPI. The coverslips were mounted on glass slides with
Vectashield and analyzed using a Zeiss LSM-710 confocal microscope.
Chromatin Immunoprecipitation Assay
Cells were fixed with 1% formaldehyde, quenched with 0.125 M glycine, and
pelleted in PBS. Pellets were lysed in buffer A (5 mM PIPES, 85 mM KCl,
0.5%NP40). Nuclear pellets were isolated by centrifugation and lysed in buffer
B (50mMTris [pH 8], 10mMEDTA [pH 8], 0.2%SDS) and sonicated. The chro-
matin was normalized and incubated with 2 mg of the indicated antibodies
overnight. Chromatin-antibody conjugates were precipitated with magnetic
beads and washed with Dilution IP buffer (16.7 mM Tris [pH 8], 1.2 mM
EDTA, 167 mM NaCl, 0.1% SDS, 1.1% Triton X-100), TSE (20 mM Tris
[pH 8], 2 mM EDTA [pH 8], 500 mM NaCl, 1% Triton X-100, and 0.1% SDS),
LiCl buffer (100 mM Tris [pH 8], 500 mM LiCl, 1% deoxycholic acid, and 1%
NP40), and TE (10 mM Tris [pH 8] and 1 mM EDTA [pH 8]). Beads were eluted
in 50 mM NaHCO3, 140 mM NaCl, and 1% SDS, decrosslinked, and bound
DNA was analyzed by dot blot using a telomere-specific probe.
Terminal Restriction Fragment Analysis
Genomic DNA was purified using the QIAGEN DNA Blood Mini Kit according
to the manufacturer’s instructions. DNA was digested with AluI and MboI re-
striction enzymes and then electrophoresed on 0.7% agarose gel in 0.53
TBE buffer. After electrophoresis, the DNA was transferred to a Hybond XL
membrane capillary action, and telomeric restriction fragments were detected
by Southern blot using a DIG-labeled probe (CCCTAA)4.
C-circle Assay
Genomic DNA was purified and digested with AluI and MboI restriction en-
zymes. The digested DNA was again purified, and the DNA was quantified
by spectrophotometer. The DNA (40 ng) was diluted in 10 ml 1 3 F29 Buffer
containing BSA (0.2 mg/ml), 0.1% Tween, 0.2 mM each dATP, dGTP, dTTP,
and incubated in the presence or absence of 7.5 U FDNA polymerase at
30C for 8 hr, followed by 65C for 20 min. C-circle amplification products
were detected by dot blot using a DIG-labeled probe (CCCTAA)4.
Metaphase Spreads
Cells were incubated in nocodazole for 2 hr, collected by trypsinization, and
then incubated in 75 mM KCl at 37C for 20 min. Cells were fixed in ice cold
fixative (3:1 methanol/acetic acid) before dropping on glass slides. Slides
were incubated with Giemsa for 20 min and analyzed with a Nikon Eclipse Ti
at 633.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.01.011.
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